Literature DB >> 28101244

Celery extract inhibits mouse CYP2A5 and human CYP2A6 activities via different mechanisms.

Xiao Deng1, Qianghong Pu1, Erhao Wang1, Chao Yu1.   

Abstract

Human cytochrome P450 (CYP) 2A6 participates in the metabolism of nicotine and precarcinogens, thus the deliberate inhibition of CYP2A6 may reduce cigarette consumption and therefore reduce the risk of developing the types of cancer associated with smoking. The inhibitory effects and mechanisms of celery (Apium graveolens) extract on mouse CYP2A5 and human CYP2A6 activity remain unclear. These effects were investigated in mouse and human liver microsomes using coumarin 7-hydroxylation in a probe reaction. Celery extract reduced CYP2A5 and CYP2A6 activities in vitro in a dose-dependent manner. In vivo experiments also showed that celery extract markedly decreased CYP2A5 activity. The inhibition of celery extract on CYP2A5 was time- and nicotinamide adenine dinucleotide phosphate (NADPH)-independent, and was markedly reduced by ultracentrifugation. Additionally, the inhibition of celery extract on CYP2A6 was time and NADPH-dependent. Levels of inhibition were characterized by a Ki, the measure of the tightness of bonds between the enzyme and its inhibitor, of 266.4 µg/ml for CYP2A5, and a Ki of 1,018 µg/ml and Kinact of 0.3/min for CYP2A6. Kinact is the maximal rate of enzyme inactivation at a saturating concentration of inhibitor. The coumarin derivative 5-methoxypsoralen present in celery extract did not solely to the inhibition of CYP2A5/6 activity. In conclusion, celery extract inhibited the levels of mouse CYP2A5 and human CYP2A6 activity via different mechanisms: Mixed competitive inhibition for CYP2A5 and mechanism-based inhibition for CYP2A6.

Entities:  

Keywords:  Apium graveolens; coumarin 7-hydroxylase; mechanism-based inhibition

Year:  2016        PMID: 28101244      PMCID: PMC5228217          DOI: 10.3892/ol.2016.5317

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition.

Authors:  Ji-Yoon Lee; Sang Yoon Lee; Soo Jin Oh; Ki Ho Lee; Young Suk Jung; Sang Kyum Kim
Journal:  Chem Biol Interact       Date:  2012-05-28       Impact factor: 5.192

Review 2.  Alteration of the substrate specificity of mouse 2A P450s by the identity of residue-209: steroid-binding site and orientation.

Authors:  M Negishi; M Iwasaki; R O Juvonen; K Aida
Journal:  J Steroid Biochem Mol Biol       Date:  1992-12       Impact factor: 4.292

Review 3.  CYP2A6: genetics, structure, regulation, and function.

Authors:  Hannu Raunio; Minna Rahnasto-Rilla
Journal:  Drug Metabol Drug Interact       Date:  2012-05-05

4.  CYP2A6 gene deletion reduces susceptibility to lung cancer.

Authors:  M Miyamoto; Y Umetsu; H Dosaka-Akita; Y Sawamura; J Yokota; H Kunitoh; N Nemoto; K Sato; N Ariyoshi; T Kamataki
Journal:  Biochem Biophys Res Commun       Date:  1999-08-11       Impact factor: 3.575

Review 5.  Genetic variability in CYP2A6 and the pharmacokinetics of nicotine.

Authors:  Jill C Mwenifumbo; Rachel F Tyndale
Journal:  Pharmacogenomics       Date:  2007-10       Impact factor: 2.533

6.  More potent inhibition of human CYP2A6 than mouse CYP2A5 enzyme activities by derivatives of phenylethylamine and benzaldehyde.

Authors:  M Rahnasto; H Raunio; A Poso; R O Juvonen
Journal:  Xenobiotica       Date:  2003-05       Impact factor: 1.908

7.  The effect of celery and parsley juices on pharmacodynamic activity of drugs involving cytochrome P450 in their metabolism.

Authors:  V Jakovljevic; A Raskovic; M Popovic; J Sabo
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Jul-Sep       Impact factor: 2.441

Review 8.  Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.

Authors:  Miki Nakajima
Journal:  Curr Opin Mol Ther       Date:  2007-12

Review 9.  Chemistry, technology, and nutraceutical functions of celery (Apium graveolens L.): an overview.

Authors:  H B Sowbhagya
Journal:  Crit Rev Food Sci Nutr       Date:  2014       Impact factor: 11.176

10.  Activation of aflatoxin B1 by mouse CYP2A enzymes and cytotoxicity in recombinant yeast cells.

Authors:  P Pelkonen; M A Lang; C P Wild; M Negishi; R O Juvonen
Journal:  Eur J Pharmacol       Date:  1994-11-01       Impact factor: 4.432

View more
  3 in total

Review 1.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

2.  The Effectiveness of Dietary Byproduct Antioxidants on Induced CYP Genes Expression and Histological Alteration in Piglets Liver and Kidney Fed with Aflatoxin B1 and Ochratoxin A.

Authors:  Roua Gabriela Popescu; Cristina Bulgaru; Arabela Untea; Mihaela Vlassa; Miuta Filip; Anca Hermenean; Daniela Marin; Ionelia Țăranu; Sergiu Emil Georgescu; Anca Dinischiotu
Journal:  Toxins (Basel)       Date:  2021-02-15       Impact factor: 4.546

3.  Indonesian herbal medicine prevents hypertension-induced left ventricular hypertrophy by diminishing NADPH oxidase-dependent oxidative stress.

Authors:  Erna Sulistyowati; Jong-Hau Hsu; Yuan-Bin Cheng; Fang-Rong Chang; Ying-Fu Chen; Jwu-Lai Yeh
Journal:  Oncotarget       Date:  2017-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.